Medical NewsGerman Drug Data (Deutsch)
Norwegian Drug Data (Norge)
Netherlands Drug Data (Nederlands)
Swedish Drug Data (Sverige)
Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here
epgonline.org is not responsible for content on any 3rd party website
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
| Drug class description : | Inactivated viruses (vaccines). |
| Generic Name : | Hepatitis A virus |
| Drug description : | Havrix Monodose: pre-filled syringe. Havrix Junior Monodose: pre- filled syringe. |
| Presentation : | Havrix Monodose: Hepatitis A virus HM 175 strain 1440 ELISA units per mL adsorbed on aluminium hydroxide. Havrix Junior Monodose: Hepatitis A virus HM 175 strain 720 ELISA units per 0 .5mL adsorbed on aluminium hydroxide. |
| Indications : | Active immunisation against hepatitis A. |
| Adult Dosage : | Havrix Monodose: Over 16 years, primary immunisation: 1 mL by intramuscular injection into deltoid muscle. Booster: 1 mL by intramuscular injection 6 - 12 months following initial dose. Havrix Junior Monodose: Over 16 years, use Havrix Monodose. |
| Child Dosage : | Havrix Monodose: Under 16 years, Havrix Monodose: Under 16 years, use Havrix Junior Monodose. Havrix Junior Monodose: Under 1 year, not recommended; 1 - 15 years, primary immunisation: 0.5 mL. Booster: 0.5 mL 6 - 12 months following initial dose. All by intramuscular injection into deltoid muscle. |
| Contra Indications : | Severe febrile infections. |
| Special Precautions : | Start new paediatric patients with Junior Monodose; existing paediatric patients should complete their primary immunisation and booster with the original Junior formulation. Infection, haemodialysis, altered immunity. Pregnancy, lactation. |
| Adverse Reactions : | Mild transient soreness, erythema and induration at inj. site. Fever, malaise, fatigue, nausea, loss of appetite. |
| Manufacturer : | GlaxoSmithKline(GSK) |
| Drug Availability : | (POM) |
Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.
Already Registered?
Please log-in now using our member login box.
Not a member?
Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.
Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.
As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!
REGISTER today it only takes a minute! and it's FREE
Having problems?
Use our forgotten password facility or email us at: contact@epgonline.org